Catamaran Corporation, a leading player in the healthcare industry, is headquartered in the United States and operates extensively across North America. Founded in 2013, the company has rapidly established itself as a key provider of pharmacy benefit management (PBM) services, focusing on optimising medication costs and improving patient outcomes. Catamaran's innovative approach combines advanced technology with personalised care, offering unique solutions that set it apart in the competitive landscape. The company’s core services include formulary management, clinical programmes, and cost containment strategies, all designed to enhance the efficiency of healthcare delivery. With a commitment to transparency and customer-centric solutions, Catamaran Corporation has achieved significant market recognition, positioning itself as a trusted partner for health plans and employers seeking to navigate the complexities of prescription drug management.
How does Catamaran Corporation's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Computer Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Catamaran Corporation's score of 80 is higher than 88% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Catamaran Corporation, headquartered in the US, currently does not report specific carbon emissions data, as indicated by the absence of emissions figures. The company is a current subsidiary of UnitedHealth Group Incorporated, which cascades its climate commitments and emissions data down to Catamaran. While no direct emissions data is available, Catamaran Corporation aligns with the climate initiatives of its parent company, UnitedHealth Group. This includes adherence to Science Based Targets Initiative (SBTi) standards and participation in the Carbon Disclosure Project (CDP). However, specific reduction targets or achievements for Catamaran Corporation itself have not been disclosed. As part of its corporate family, Catamaran is expected to follow the sustainability and emissions reduction strategies set forth by UnitedHealth Group, which may include commitments to reducing Scope 1, 2, and 3 emissions. The absence of specific data highlights the need for further transparency in reporting emissions and climate commitments at the subsidiary level.
Access structured emissions data, company-specific emission factors, and source documents
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|
| Scope 1 | 15,838,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 2 | 161,303,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 |
| Scope 3 | 146,373,000 | 000,000,000 | 000,000,000 | 000,000,000 | 000,000,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 | 00,000,000,000 |
Catamaran Corporation's Scope 3 emissions, which decreased by 3% last year and increased significantly since 2016, demonstrating supply chain emissions tracking. Nearly all of their carbon footprint comes from suppliers and value chain emissions, representing nearly all emissions under the GHG Protocol, with "Investments" being the largest emissions source at 51% of Scope 3 emissions.
Climate goals typically focus on 2030 interim targets and 2050 net-zero commitments, aligned with global frameworks like the Paris Agreement and Science Based Targets initiative (SBTi) to ensure alignment with global climate goals.
Catamaran Corporation has not publicly committed to specific 2030 or 2050 climate goals through the major frameworks we track. Companies often set interim 2030 targets and long-term 2050 net-zero goals to demonstrate measurable progress toward decarbonization.